Evidence map›Paper›PMID 27570521›Full record

ArticleFrontiers in microbiology2016

Common Genetic Polymorphisms within NFκB-Related Genes and the Risk of Developing Invasive Aspergillosis.

Carmen B Lupiañez, María T Villaescusa, Agostinho Carvalho, Jan Springer, Michaela Lackner, José M Sánchez-Maldonado, Luz M Canet, Cristina Cunha, Juana Segura-Catena, Laura Alcazar-Fuoli and 15 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Polymorphisms within theJournal of fungi (Basel, Switzerland) · 2020
    Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 11 institutions in 5 countries.

Carmen B LupiañezGenomic Oncology Area, GENYO, Center for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, PTS GranadaGranada, Spain; Hematology Department, Virgen de las Nieves University HospitalGranada, Spain.
María T VillaescusaHematology Department, University Hospital of SalamancaSalamanca, Spain; Hematology Department, Jiménez Díaz FoundationMadrid, Spain.
Agostinho CarvalhoLife and Health Sciences Research Institute (ICVS), School of Health Sciences, University of MinhoBraga, Portugal; ICVS/3B's - PT Government Associate LaboratoryBraga, Portugal.
Jan SpringerUniversitätsklinikum Würzburg, Medizinische Klinik II Würzburg, Germany.
Michaela LacknerDivision of Hygiene and Medical Microbiology, Medical University of Innsbruck Innsbruck, Austria.
José M Sánchez-MaldonadoGenomic Oncology Area, GENYO, Center for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, PTS Granada Granada, Spain.
Luz M CanetGenomic Oncology Area, GENYO, Center for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, PTS Granada Granada, Spain.
Cristina CunhaLife and Health Sciences Research Institute (ICVS), School of Health Sciences, University of MinhoBraga, Portugal; ICVS/3B's - PT Government Associate LaboratoryBraga, Portugal.
Juana Segura-CatenaGenomic Oncology Area, GENYO, Center for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, PTS GranadaGranada, Spain; Hematology Department, Virgen de las Nieves University HospitalGranada, Spain.
Laura Alcazar-FuoliMycology Reference Laboratory, Centro Nacional de Microbiología, Instituto de Salud Carlos III Madrid, Spain.
Carlos SolanoHematology Department, Clinic University Hospital of Valencia Valencia, Spain.
Luana FianchiIstituto di Ematologia, Università Cattolica del S. Cuore Rome, Italy.
Livio PaganoIstituto di Ematologia, Università Cattolica del S. Cuore Rome, Italy.
Leonardo PotenzaDepartment of Medical and Surgical Sciences, University of Modena and Reggio Emilia AOU Policlinico, Modena, Italy.
José M AguadoUnit of Infectious Diseases, University Hospital 12 de Octubre, Research Institute of Hospital 12 de Octubre (i+12) Madrid, Spain.
Mario LuppiDepartment of Medical and Surgical Sciences, University of Modena and Reggio Emilia AOU Policlinico, Modena, Italy.
Manuel Cuenca-EstrellaMycology Reference Laboratory, Centro Nacional de Microbiología, Instituto de Salud Carlos III Madrid, Spain.
Cornelia Lass-FlörlDivision of Hygiene and Medical Microbiology, Medical University of Innsbruck Innsbruck, Austria.
Hermann EinseleUniversitätsklinikum Würzburg, Medizinische Klinik II Würzburg, Germany.
Lourdes VázquezHematology Department, University Hospital of Salamanca Salamanca, Spain.
PCRAGA Study Group
Rafael Ríos-TamayoGenomic Oncology Area, GENYO, Center for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, PTS GranadaGranada, Spain; Hematology Department, Virgen de las Nieves University HospitalGranada, Spain.
Jurgen LoefflerUniversitätsklinikum Würzburg, Medizinische Klinik II Würzburg, Germany.
Manuel JuradoGenomic Oncology Area, GENYO, Center for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, PTS GranadaGranada, Spain; Hematology Department, Virgen de las Nieves University HospitalGranada, Spain.
Juan SainzGenomic Oncology Area, GENYO, Center for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, PTS GranadaGranada, Spain; Hematology Department, Virgen de las Nieves University HospitalGranada, Spain.
Pfizer-University of Granada-Junta de Andalucía Centre for Genomics and Oncological Research · ESUniversitätsklinikum Würzburg · DEInstituto de Salud Carlos III · ESUniversidad de Salamanca · ESUniversità Cattolica del Sacro Cuore · ITUniversity of Minho · PTUniversity of Modena and Reggio Emilia · ITHospital Clínico Universitario de Valencia · ESInnsbruck Medical University · ATResearch Institute Hospital 12 de Octubre · ESUniversität Innsbruck · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Invasive Aspergillosis (IA) is an opportunistic infection caused by Aspergillus, a ubiquitously present airborne pathogenic mold. A growing number of studies suggest a major host genetic component in disease susceptibility. Here, we evaluated whether 14 single-nucleotide polymorphisms within NFκB1, NFκB2, RelA, RelB, Rel, and IRF4 genes influence the risk of IA in a population of 834 high-risk patients (157 IA and 677 non-IA) recruited through a collaborative effort involving the aspBIOmics consortium and four European clinical institutions. No significant overall associations between selected SNPs and the risk of IA were found in this large cohort. Although a hematopoietic stem cell transplantation (HSCT)-stratified analysis revealed that carriers of the IRF4 rs12203592T/T genotype had a six-fold increased risk of developing the infection when compared with those carrying the C allele (ORREC = 6.24, 95%CI 1.25-31.2, P = 0.026), the association of this variant with IA risk did not reach significance at experiment-wide significant threshold. In addition, we found an association of the IRF4AATC and IRF4GGTC haplotypes (not including the IRF4 rs12203592T risk allele) with a decreased risk of IA but the magnitude of the association was similar to the one observed in the single-SNP analysis, which indicated that the haplotypic effect on IA risk was likely due to the IRF4 rs12203592 SNP. Finally, no evidence of significant interactions among the genetic markers tested and the risk of IA was found. These results suggest that the SNPs on the studied genes do not have a clinically relevant impact on the risk of developing IA.

Indexed as

genetic polymorphismsinteractionInvasive AspergillosisNFκB-related genessusceptibility

Identifiers

PMID27570521
PMCPMC4982195
OpenAlexW2517376112

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.